Media Pooling Strategy Added to SARS-CoV-2 RT-PCR Test
The ViroKey SARS-CoV-2 RT-PCR Test v2.0 has the additional capability to be used for pooling, using a three-in-one media pooling strategy.
Category: POC Rapid Assays
POC Rapid Assays
Latest
POC Rapid Assays
Latest
LumiraDx’s COVID-19 Antigen Test Expanded to Include Screening of Asymptomatic Individuals
LumiraDx announced that the intended use for its FDA EUA-authorized SARS-CoV-2 Antigen Test has been expanded to include asymptomatic individuals.
POC Rapid Assays
Latest
Partnership Facilitates COVID Testing Process for U.S. Travelers
ARCpoint Labs is utilizing its national network of diagnostic testing facilities to help travelers find convenient locations for COVID-19 testing.
LumiraDx Receives FDA EUA for its COVID-19 Antibody Test
LumiraDx has announced receiving FDA EUA for its SARS-CoV-2 Ab test, which is used to help identify an adaptive immune response to SARS-CoV-2.
Read More
NanoDx Collaborates with IBM Research on Sensors for Rapid Diagnostic Testing
NanoDx, Inc., has entered into a licensing agreement with IBM Research for use of its nanoscale sensors for accurate, rapid testing.
Read More
AI App Could Lead to More Accurate HIV Diagnoses
Technology developed by UCL and AHRI researchers could transform the ability to accurately interpret HIV test results.
Read More
Roche SARS-CoV-2 Molecular Test Granted FDA EUA
Roche has announced that the U.S. FDA has granted EUA for the cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System.
Read More
How Better Diagnostics Technology Could Thwart Tomorrow’s Pandemics
Pandemic preparedness requires long-term investments in disease surveillance, diagnostics, therapeutics, and vaccine research.
Read More
BD, ImageMover Collaborate for Rapid Antigen Test Reporting
The reporting app helps facilitate SARS-CoV-2 testing and result reporting from BD Veritor Plus System.
Read More
Home Testing for Covid-19 Could Prevent Infections and Reduce Deaths at Justifiable Cost
Mailing a package of SARS-CoV-2 tests to every household in America and asking people to use them once a week could greatly reduce total infections and mortality at a justifiable cost, according to a study led by the Yale School of Public Health.
Read More
Quidel QuickVue At-Home Covid-19 Test Receives EUA
The antigen test enables certain individuals to rapidly collect and test their samples at home without needing to send them to a laboratory for analysis.
Read More
LightDeck Diagnostics Awarded $5.65M to Develop a Covid-19 Rapid Antigen Test
These funds will enable the company to develop a point-of-care antigen test that delivers results in less than 6 minutes.
Read More
Abbott’s Covid-19 Antigen Test May Help with Faster Detection, Isolation, Per the CDC
A study from the CDC found that BinaxNOW catches most infectious cases but may miss nearly two-thirds of covid-19 infections in people without symptoms.
Read More
QuantuMDx Scales Up to Mass Manufacture Q-POC
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read More
EUA for Quidel’s QuickVue SARS Rapid Antigen Test
The easy-to-use, visually read test could expand testing for covid-19 to diverse point-of-care locations.
Read More
New FDA Authorization for the BinaxNow Covid-19 Ag Card Home Test
Abbott and eMed expect to deliver and administer 30 million BinaxNow tests in the first quarter of 2021, with an additional 90 million in the second quarter.
Read More
FDA Authorizes First Covid-19 Test for Self-Testing at Home
The Lucira Covid-19 All-In-One Test Kit is a molecular (real-time loop mediated amplification reaction) single-use test that is intended to detect the novel coronavirus SARS-CoV-2 that causes covid-19.
Read More
BARDA Further Funds Inflammatix ViraBac EZ Acute Infection Test
This additional BARDA funding supports a test designed to read the immune system and rapidly diagnose acute infection at the point of care.
Read More